Literature DB >> 10523640

Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein.

J Turkson1, T Bowman, J Adnane, Y Zhang, J Y Djeu, M Sekharam, D A Frank, L B Holzman, J Wu, S Sebti, R Jove.   

Abstract

Signal transducers and activators of transcription (STATs) are transcription factors that mediate normal biologic responses to cytokines and growth factors. However, abnormal activation of certain STAT family members, including Stat3, is increasingly associated with oncogenesis. In fibroblasts expressing the Src oncoprotein, activation of Stat3 induces specific gene expression and is required for cell transformation. Although the Src tyrosine kinase induces constitutive Stat3 phosphorylation on tyrosine, activation of Stat3-mediated gene regulation requires both tyrosine and serine phosphorylation of Stat3. We investigated the signaling pathways underlying the constitutive Stat3 activation in Src oncogenesis. Expression of Ras or Rac1 dominant negative protein blocks Stat3-mediated gene regulation induced by Src in a manner consistent with dependence on p38 and c-Jun N-terminal kinase (JNK). Both of these serine/threonine kinases and Stat3 serine phosphorylation are constitutively induced in Src-transformed fibroblasts. Furthermore, inhibition of p38 and JNK activities suppresses constitutive Stat3 serine phosphorylation and Stat3-mediated gene regulation. In vitro kinase assays with purified full-length Stat3 as the substrate show that both JNK and p38 can phosphorylate Stat3 on serine. Moreover, inhibition of p38 activity and thus of Stat3 serine phosphorylation results in suppression of transformation by v-Src but not v-Ras, consistent with a requirement for Stat3 serine phosphorylation in Src transformation. Our results demonstrate that Ras- and Rac1-mediated p38 and JNK signals are required for Stat3 transcriptional activity induced by the Src oncoprotein. These findings delineate a network of tyrosine and serine/threonine kinase signaling pathways that converge on Stat3 in the context of oncogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523640      PMCID: PMC84756          DOI: 10.1128/MCB.19.11.7519

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  78 in total

1.  Fibroblast transformation by Fps/Fes tyrosine kinases requires Ras, Rac, and Cdc42 and induces extracellular signal-regulated and c-Jun N-terminal kinase activation.

Authors:  J Li; T E Smithgall
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

2.  A mammalian scaffold complex that selectively mediates MAP kinase activation.

Authors:  A J Whitmarsh; J Cavanagh; C Tournier; J Yasuda; R J Davis
Journal:  Science       Date:  1998-09-11       Impact factor: 47.728

3.  Activation of STAT transcription factors by herpesvirus Saimiri Tip-484 requires p56lck.

Authors:  T C Lund; R Garcia; M M Medveczky; R Jove; P G Medveczky
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

4.  Phosphatidylinositol 3-kinase functions upstream of Ras and Raf in mediating insulin stimulation of c-fos transcription.

Authors:  K Yamauchi; K Holt; J E Pessin
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

5.  Identification and characterization of a new mammalian mitogen-activated protein kinase kinase, MKK2.

Authors:  J Wu; J K Harrison; P Dent; K R Lynch; M J Weber; T W Sturgill
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

6.  Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells.

Authors:  H Yano; S Nakanishi; K Kimura; N Hanai; Y Saitoh; Y Fukui; Y Nonomura; Y Matsuda
Journal:  J Biol Chem       Date:  1993-12-05       Impact factor: 5.157

7.  Dual phosphorylation and autophosphorylation in mitogen-activated protein (MAP) kinase activation.

Authors:  J H Her; S Lakhani; K Zu; J Vila; P Dent; T W Sturgill; M J Weber
Journal:  Biochem J       Date:  1993-11-15       Impact factor: 3.857

8.  AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells.

Authors:  A X Liu; J R Testa; T C Hamilton; R Jove; S V Nicosia; J Q Cheng
Journal:  Cancer Res       Date:  1998-07-15       Impact factor: 12.701

Review 9.  Activation of STAT transcription factors in oncogenic tyrosine kinase signaling.

Authors:  R Garcia; R Jove
Journal:  J Biomed Sci       Date:  1998       Impact factor: 8.410

10.  Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase.

Authors:  S A Moodie; B M Willumsen; M J Weber; A Wolfman
Journal:  Science       Date:  1993-06-11       Impact factor: 47.728

View more
  76 in total

1.  Protein kinase PKR is required for platelet-derived growth factor signaling of c-fos gene expression via Erks and Stat3.

Authors:  A Deb; M Zamanian-Daryoush; Z Xu; S Kadereit; B R Williams
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

2.  v-Src generates a p53-independent apoptotic signal.

Authors:  B L Webb; E Jimenez; G S Martin
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

3.  A novel bayesian graphical model for genome-wide multi-SNP association mapping.

Authors:  Yu Zhang
Journal:  Genet Epidemiol       Date:  2011-11-29       Impact factor: 2.135

4.  Toxin-induced RhoA activity mediates CCL1-triggered signal transducers and activators of transcription protein signaling.

Authors:  Simone Reipschläger; Katharina Kubatzky; Sanaz Taromi; Meike Burger; Joachim Orth; Klaus Aktories; Gudula Schmidt
Journal:  J Biol Chem       Date:  2012-02-06       Impact factor: 5.157

5.  A common signaling cascade may underlie "addiction" to the Src, BCR-ABL, and EGF receptor oncogenes.

Authors:  Sreenath V Sharma; Patrycja Gajowniczek; Inna P Way; Diana Y Lee; Jane Jiang; Yuki Yuza; Marie Classon; Daniel A Haber; Jeffrey Settleman
Journal:  Cancer Cell       Date:  2006-11       Impact factor: 31.743

Review 6.  IL-32θ: a recently identified anti-inflammatory variant of IL-32 and its preventive role in various disorders and tumor suppressor activity.

Authors:  Muhammad Babar Khawar; Maryam Mukhtar; Muddasir Hassan Abbasi; Nadeem Sheikh
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

7.  Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth.

Authors:  Paul L Leong; Genevieve A Andrews; Daniel E Johnson; Kevin F Dyer; Sichuan Xi; Jeffrey C Mai; Paul D Robbins; Seshu Gadiparthi; Nancy A Burke; Simon F Watkins; Jennifer Rubin Grandis
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-14       Impact factor: 11.205

8.  Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology.

Authors:  D Kontoyiannis; A Kotlyarov; E Carballo; L Alexopoulou; P J Blackshear; M Gaestel; R Davis; R Flavell; G Kollias
Journal:  EMBO J       Date:  2001-07-16       Impact factor: 11.598

9.  Drosophila C-terminal Src kinase negatively regulates organ growth and cell proliferation through inhibition of the Src, Jun N-terminal kinase, and STAT pathways.

Authors:  Renee D Read; Erika A Bach; Ross L Cagan
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

10.  Hepatitis B virus X protein activates the p38 mitogen-activated protein kinase pathway in dedifferentiated hepatocytes.

Authors:  Chi Tarn; Lin Zou; Ronald L Hullinger; Ourania M Andrisani
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.